← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 21, 2017Last known activity
Dec 10, 2025
Timeline
2000s
- Jan 1, 2009
Alphamab Co., Ltd.— Founded
Drugs by trial phase (35 distinct, 48 trials)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Digestive System Neoplasms
- Esophageal Squamous Cell Carcinoma
- Gastrointestinal Neoplasms
- Infertility
- Infertility, Female
- Lung Neoplasms
- Lymphoma
- Neoplasms
- Stomach Neoplasms
- Thymoma
- Triple Negative Breast Neoplasms
Recent trials (48)
- NCT07283198Lead sponsorPhase 2Dec 10, 2025
- NCT07292402Lead sponsorPhase 1Oct 23, 2025
- NCT06747416Lead sponsorPhase 2Sep 2, 2025
- NCT07201467Lead sponsorPhase 1/Phase 2Aug 22, 2025
- NCT07191899Lead sponsorPhase 1Aug 5, 2025
- NCT06942234Lead sponsorPhase 1/Phase 2Jun 1, 2025
- NCT06868732Lead sponsorPhase 1Mar 12, 2025
- NCT06775483Lead sponsorPhase 2Jan 17, 2025
- NCT06770881Lead sponsorPhase 1/Phase 2Jan 15, 2025
- NCT06751485Lead sponsorPhase 3Jan 15, 2025
- NCT06547775Lead sponsorPhase 1Aug 2, 2024
- NCT06592417Lead sponsorPhase 1Apr 30, 2024
- NCT06569108Lead sponsorPhase 3Apr 1, 2024
- NCT06226766Lead sponsorPhase 1/Phase 2Jan 18, 2024
- NCT06312475Lead sponsorPhase 3Jan 9, 2024
Details
- Founded
- Suzhou, CN Jan 1, 2009
- Last known activity
- Dec 10, 2025